CIK 0001808158
RPTX Repare Therapeutics Inc.
Insider trading from SEC Form 4. Last filing Jan 30, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at Repare Therapeutics Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Steve Forte EVP, CHIEF FINANCIAL OFFICER sell | $7,848 6,884 shares | -11% | - | |
| 23Weak | Maria Koehler EVP, CHIEF MEDICAL OFFICER sell | $4,099 3,596 shares | -2% | - |
Transactions
The last 23 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | Bvf Partners L P/il owner | UTender of shares Common Shares, no par value | -5,309,432 | - | - | 0 | Jan 30, 2026 |
| Jan 28, 2026 | Bvf Partners L P/il owner | UTender of shares Common Shares, no par value | -4,308,573 | - | - | 0 | Jan 30, 2026 |
| Jan 28, 2026 | Bvf Partners L P/il owner | UTender of shares Common Shares, no par value | -548,938 | - | - | 0 | Jan 30, 2026 |
| Jan 28, 2026 | Thomas Civik director | DDisposition to issuer Common Shares | -7,500 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | DDisposition to issuer Common Shares | -56,786 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Sandra Isabelle Barros Alves SVP, Finance and CAO | DDisposition to issuer Common Shares | -31,622 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Ann D Rhoads director | DDisposition to issuer Common Shares | -4,000 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Carol Schafer director | DDisposition to issuer Common Shares | -8,000 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Sandra Isabelle Barros Alves SVP, Finance and CAO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -26,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -200,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Carol Schafer director | DDisposition to issuer Stock Option (right to buy)derivative | -37,941 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Sandra Isabelle Barros Alves SVP, Finance and CAO | DDisposition to issuer Employee Stock Option (right to buy)derivative | -24,500 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -85,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -500,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -325,800 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Apr 2, 2025 | Sandra Isabelle Barros Alves SVP, Finance and CAO | AGrant or award Common Shares | +4,100 | $0.00 | $0 | 29,622 | Apr 29, 2025 |
| Apr 2, 2025 | Sandra Isabelle Barros Alves SVP, Finance and CAO | AGrant or award Employee Stock Option (right to buy)derivative | +24,500 | $0.00 | $0 | 24,500 | Apr 29, 2025 |
| Apr 2, 2025 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Apr 4, 2025 |
| Mar 12, 2025 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | SOpen-market sale Common Shares | -6,884 | $1.14 | $7,848 | 54,786 | Mar 14, 2025 |
| Mar 12, 2025 | Maria Koehler EVP, CHIEF MEDICAL OFFICER | SOpen-market sale Common Shares | -3,596 | $1.14 | $4,099 | 227,813 | Mar 14, 2025 |
| Mar 4, 2025 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | AGrant or award Common Shares | +14,000 | $0.00 | $0 | 61,670 | Mar 6, 2025 |
| Mar 4, 2025 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Mar 6, 2025 |
| Mar 4, 2025 | Steve Forte EVP, CHIEF FINANCIAL OFFICER | AGrant or award Employee Stock Option (right to buy)derivative | +85,000 | $0.00 | $0 | 85,000 | Mar 6, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Sandra Isabelle Barros AlvesSVP, Finance and CAO
- Bvf Partners L P/ilother, owner, director
- Thomas Civikceo, chair, officer, director
- Steve ForteEVP, CHIEF FINANCIAL OFFICER
- Maria KoehlerEVP, CHIEF MEDICAL OFFICER
- Ann D Rhoadsdirector
- Carol Schaferdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.